Unisec

Press releases

2016

BiondVax’s Universal Flu Vaccine Phase 2b Clinical Trial Recruitment Complete
UNISEC website (link)
March 28, 2016

2016

The UNISEC consortium has started a clinical trial study for one of its Universal Influenza Vaccines
UNISEC website (link)
March 9, 2016

2015

The regulatory approval was received for the trial enabling BiondVax to examine its vaccine as a primer for an Avian (H5N1) flu pandemic outbreak in collaboration with the UNISEC European Consortium
BiondVax website (link)
September 30, 2015

2015

BiondVax Announces Successful Recruitment of the First Participants in a Phase IIb Clinical Trial in Europe with its Universal Flu Vaccine: Multimeric M-001
BiondVax website (link)
October 21, 2015